Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added related topics to the page: Type 2 diabetes and MedlinePlus Genetics. This aligns the page with the study's subject and improves navigation to related information.
    Difference
    0.1%
    Check dated 2026-03-26T04:02:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.0, replacing the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:50:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision note (v3.4.3) was added, and several related topics including Type 2 diabetes, MedlinePlus Genetics, and the previous revision reference (v3.4.2) were removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:17:46.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added related topics MedlinePlus Genetics and Type 2 diabetes for additional context, without altering the study's core information.
    Difference
    0.1%
    Check dated 2026-03-04T14:16:49.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Removed 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics' from the related topics section. This alters the visible topic signals and may affect discoverability for users seeking information on type 2 diabetes and related genetics resources.
    Difference
    0.1%
    Check dated 2026-02-25T10:43:44.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T05:49:42.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.